Mechanisms of carbapenem resistance in non-metallo-β-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital
- 31 December 2009
- journal article
- Published by Elsevier BV in Pathologie Biologie
- Vol. 57 (7-8), 530-535
- https://doi.org/10.1016/j.patbio.2008.09.001
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)Clinical Microbiology & Infection, 2006
- Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolatesAPMIS, 2005
- Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospitalDiagnostic Microbiology and Infectious Disease, 2004
- Insertional inactivation ofoprD in clinical isolates ofPseudomonas aeruginosaleading to carbapenem resistanceFEMS Microbiology Letters, 2004
- C-Terminal Region of Pseudomonas aeruginosa Outer Membrane Porin OprD Modulates Susceptibility to MeropenemAntimicrobial Agents and Chemotherapy, 2001
- Of Pseudomonas, porins, pumps and carbapenemsJournal of Antimicrobial Chemotherapy, 2001
- Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2001
- Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in FranceAntimicrobial Agents and Chemotherapy, 2000
- Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical IsolateAntimicrobial Agents and Chemotherapy, 1999
- In Vivo Emergence of Multidrug-Resistant Mutants of Pseudomonas aeruginosa Overexpressing the Active Efflux System MexA-MexB-OprMAntimicrobial Agents and Chemotherapy, 1999